AstraZeneca saw its shares falling on Monday after the pharmaceutical giant announced its $39 billion plan to acquire rare-diseases biotech Alexion Pharmaceuticals. Shares closed down 7.81% on Monday as Wall Street digested the news. As part of the deal, Alexion shareholders will receive $60 in cash and 2.1243 AstraZeneca American Depositary Shares (ADSs) (each ADS … Continue reading “AstraZeneca Shares Collapse on Alexion $39B Pharmaceuticals Deal”
Tag: alexion pharmaceuticals
Biotech & Pharma
Amgen and Alexion Pharmaceuticals Reach Agreement in Patent Battle
Shares of Alexion Pharmaceuticals were soaring on Thursday and Friday after the company along with…
May 29, 2020
Biotech & Pharma
This U.S Drug maker Just Said it Will Lay off 20% of Its Workforce
U.S drug maker Alexion announced this week that it would be slashing 20% of its…
September 12, 2017